Søgeresultater - Davide Agnoletti
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypert... af Chahine, Jirar Topouchian, Jacques Blacher, Nathalie Assemani, Roland Asmar, Isabel Ibanez, Davide Agnoletti, Ahmed E. Youssef
Udgivet 2014Artigo -
7
Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes af Federica Piani, Davide Agnoletti, Alessandro Baracchi, Sara Scarduelli, Carmine Verde, Giovanni Tossetta, Elisa Montaguti, Giuliana Simonazzi, Daniela Degli Esposti, Claudio Borghi
Udgivet 2023Artigo -
8
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure af Filippo Valbusa, Stefano Bonapace, Davide Agnoletti, Luca Scala, Cristina Grillo, Pietro Arduini, E Turcato, Alessandro Mantovani, Giacomo Zoppini, Guido Arcaro, Christopher D. Byrne, Giovanni Targher
Udgivet 2017Artigo -
9
Mortality and Cardiovascular Events Are Best Predicted by Low Central/Peripheral Pulse Pressure Amplification But Not by High Blood Pressure Levels in Elderly Nursing Home Subjects af Athanase Bénétos, Sylvie Gautier, Carlos Labat, Paolo Salvi, Filippo Valbusa, Francesca Marino, Olivier Toulza, Davide Agnoletti, Mauro Zamboni, Delphine Dubail, Patrick Manckoundia, Yves Rolland, Olivier Hanon, Christine Perret‐Guillaume, Patrick Lacolley, Michel E. Safar, Françis Guillemin
Udgivet 2012Artigo
Søgeredskaber:
Relaterede emner
Internal medicine
Medicine
Blood pressure
Cardiology
Disease
Biology
Endocrinology
Heart failure
Myocardial infarction
Uric acid
Alternative medicine
Bioinformatics
Confidence interval
Coronary artery disease
Dyslipidemia
Environmental health
Hyperuricemia
Intensive care medicine
Pathology
Population
ACE inhibitor
Ambulatory blood pressure
Amlodipine
Angiotensin Receptor Blockers
Angiotensin-converting enzyme
Candesartan
Cirrhosis
Clinical endpoint
Clinical trial
Concomitant